| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 9340 | 2021 |
| Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Waltenberger, L Claesson-Welsh, A Siegbahn, M Shibuya, CH Heldin Journal of Biological Chemistry 269 (43), 26988-26995, 1994 | 2247 | 1994 |
| 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European … M Glikson, JC Nielsen, MB Kronborg, Y Michowitz, A Auricchio, ... EP Europace 24 (1), 71-164, 2022 | 1558 | 2022 |
| Inhibition of VEGF receptors causes lung cell apoptosis and emphysema Y Kasahara, RM Tuder, L Taraseviciene-Stewart, TD Le Cras, S Abman, ... The Journal of clinical investigation 106 (11), 1311-1319, 2000 | 1382 | 2000 |
| C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries J Torzewski, M Torzewski, DE Bowyer, M Fröhlich, W Koenig, ... Arteriosclerosis, thrombosis, and vascular biology 18 (9), 1386-1392, 1998 | 1133 | 1998 |
| The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and … M Clauss, H Weich, G Breier, U Knies, W Röckl, J Waltenberger, W Risau Journal of Biological Chemistry 271 (30), 17629-17634, 1996 | 1051 | 1996 |
| Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 M Autiero, J Waltenberger, D Communi, A Kranz, L Moons, D Lambrechts, ... Nature medicine 9 (7), 936-943, 2003 | 1016 | 2003 |
| Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension L TARASEVICIENE‐STEWART, Y Kasahara, L Alger, P Hirth, ... The FASEB Journal 15 (2), 427-438, 2001 | 1015 | 2001 |
| C-reactive protein in the arterial intima: role of C-reactive protein receptor–dependent monocyte recruitment in atherogenesis M Torzewski, C Rist, RF Mortensen, TP Zwaka, M Bienek, J Waltenberger, ... Arteriosclerosis, thrombosis, and vascular biology 20 (9), 2094-2099, 2000 | 977 | 2000 |
| A novel vascular endothelial growth factor encoded by Orf virus, VEGF‐E, mediates angiogenesis via signalling through VEGFR‐2 (KDR) but not VEGFR‐1 (Flt‐1) receptor tyrosine … M Meyer, M Clauss, A Lepple‐Wienhues, J Waltenberger, HG Augustin, ... The EMBO journal, 1999 | 717 | 1999 |
| Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts U Mayr-Wohlfart, J Waltenberger, H Hausser, S Kessler, KP Günther, ... Bone 30 (3), 472-477, 2002 | 643 | 2002 |
| The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells J Kroll, J Waltenberger Journal of Biological Chemistry 272 (51), 32521-32527, 1997 | 567 | 1997 |
| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 552 | 2018 |
| VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR) J Kroll, J Waltenberger Biochemical and biophysical research communications 252 (3), 743-746, 1998 | 482 | 1998 |
| Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice RA Brekken, JP Overholser, VA Stastny, J Waltenberger, JD Minna, ... Cancer research 60 (18), 5117-5124, 2000 | 466 | 2000 |
| Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR R Colavitti, G Pani, B Bedogni, R Anzevino, S Borrello, J Waltenberger, ... Journal of Biological Chemistry 277 (5), 3101-3108, 2002 | 458 | 2002 |
| Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science PC Evans, GE Rainger, JC Mason, TJ Guzik, E Osto, Z Stamataki, D Neil, ... Cardiovascular research 116 (14), 2177-2184, 2020 | 444 | 2020 |
| Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications J Waltenberger Cardiovascular research 49 (3), 554-560, 2001 | 431 | 2001 |
| Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38 … S Rousseau, F Houle, H Kotanides, L Witte, J Waltenberger, J Landry, ... Journal of Biological Chemistry 275 (14), 10661-10672, 2000 | 404 | 2000 |
| Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt A Wick, W Wick, J Waltenberger, M Weller, J Dichgans, JB Schulz Journal of Neuroscience 22 (15), 6401-6407, 2002 | 390 | 2002 |
